Advances in IP-10 and its genetic polymorphisms in relation to Kawasaki disease
10.3760/cma.j.issn.1673-4408.2025.06.010
- VernacularTitle:γ干扰素诱导蛋白10及其基因多态性与川崎病相关研究进展
- Author:
Meng WANG
1
;
Yanyan LIANG
;
Wanyu FENG
;
Xuewen SU
;
Hua ZHU
Author Information
1. 内蒙古医科大学,呼和浩特 010020
- Keywords:
Kawasaki disease;
IP-10;
IP-10 gene;
Chemokine
- From:
International Journal of Pediatrics
2025;52(6):405-409
- CountryChina
- Language:Chinese
-
Abstract:
Kawasaki disease(KD)is an acute systemic vasculitis primarily affecting small- and medium-sized arteries in children,with widespread inflammation as the major pathological hallmark. A subset of patients with KD exhibit resistance to high-dose intravenous immunoglobulin(IVIG)therapy,which significantly increases the risk of developing severe cardiovascular complications,particularly coronary artery lesions(CAL). Interferon gamma-inducible protein 10(IP-10),a chemokine,exerts its biological functions by binding to its specific receptor,chemokine receptor 3(CXCR3). In the relevant research on KD,the association between IP-10 and IP-10 gene polymorphism with KD has garnered significant attention from both domestic and international researchers. This article reviews the recent research progress on the relationship between IP-10,its gene polymorphism and KD,with the aim of providing references for the pathogenesis,prevention,treatment and prognosis of KD.